Expanded access and commercial packaging for niche-market drugs

被引：0
|
作者：
Jones, Karl
Stark, Matthew
机构：
来源：
Manufacturing Chemist | 2020年 / 91卷 / 01期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：26 / 28
相关论文
共 50 条
  • [41] The ‘false hope’ argument in discussions on expanded access to investigational drugs: a critical assessment
    Marjolijn Hordijk
    Stefan F. Vermeulen
    Eline M. Bunnik
    Medicine, Health Care and Philosophy, 2022, 25 : 693 - 701
  • [42] Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits
    Fountzilas, Elena
    Said, Rabih
    Tsimberidou, Apostolia M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (02) : 155 - 162
  • [43] Prescribing unproven cancer drugs: physician perspectives on expanded access and right to try
    Manley, Haley
    Sisk, Bryan A.
    Master, Zubin
    Scott, Christopher Thomas
    JOURNAL OF LAW AND THE BIOSCIENCES, 2022, 9 (02):
  • [44] Institutional Review Boards as Arbiters of Expanded Access to Unapproved Drugs: Time for a Change?
    Barbara K. Redman
    Alison Shea Bateman-House
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 515 - 516
  • [45] Estimating the lives that could be saved by expanded access to weight- loss drugs
    Pandey, Abhishek
    Ye, Yang
    Wells, Chad R.
    Singer, Burton H.
    Galvani, Alison P.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (43)
  • [46] Institutional Review Boards as Arbiters of Expanded Access to Unapproved Drugs: Time for a Change?
    Redman, Barbara K.
    Bateman-House, Alison Shea
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (04) : 515 - 516
  • [47] Market-access agreements for anti-cancer drugs
    van de Vooren, Katelijne
    Curto, Alessandro
    Freemantle, Nick
    Garattini, Livio
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2015, 108 (05) : 166 - 170
  • [48] QUALITATIVE ASSESSMENT OF SOCIETAL PREFERENCES FOR MARKET ACCESS OF CANCER DRUGS
    Pauwels, K.
    Huys, I
    Casteels, M.
    Simoens, S.
    VALUE IN HEALTH, 2015, 18 (07) : A486 - A486
  • [49] MARKET ACCESS AND PRICING ANALYSIS OF ULTRA-ORPHAN DRUGS
    Malacan, J.
    Gabriel, S.
    Dinet, J.
    Forget, S.
    Borget, I
    VALUE IN HEALTH, 2016, 19 (03) : A257 - A257
  • [50] SCAN: AN INTEGRATED SYSTEM FOR MARKET ACCESS OF NEW DRUGS IN ITALY
    Lanati, E. P.
    Lidonnici, D.
    D'Ausilio, A.
    Iorio, A.
    Jommi, C.
    VALUE IN HEALTH, 2011, 14 (07) : A425 - A425
12345